N/A
Completed N=74
Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Control During Cervical Dilator Placement Prior to Dilation and Evacuation
Pain Management
Source: ClinicalTrials.gov NCT03868787 ↗
Enrolled (actual)
74
Serious AEs
0.0%
Results posted
Jul 2023
Primary outcomePrimary: Pain Following Dilator Placement — 64; 60.5 units on a scale
Summary
This study evaluates the use of Transcutaneous Electrical Nerve Stimulation (TENS) as a method of pain control during osmotic dilator insertion prior to dilation and evacuation. Half the group will have an active TENS unit and half will have a sham or placebo TENS unit.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Pain Following Dilator Placement |
64; 60.5 | — |
| SECONDARY Interval Pain |
39; 55 | — |
| SECONDARY Patient Satisfaction |
4; 3; 5; 4; 2; 4 | — |
Eligibility Criteria
Inclusion Criteria
- Women ≥ 18 years of age
- Gestational age between 14 weeks and 23 weeks 6 days
- Willing and able to sign an informed consent in English
- No contraindications to TENS
Exclusion Criteria
- Incarceration
- Preterm Premature Rupture of Membranes or evidence of intra-amniotic infection
- Presence of implanted cardiac device
- Lack of sensation to touch on area of electrode placement
- Prior TENS use
- Opioid dependence
Data sourced from ClinicalTrials.gov (NCT03868787). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.